The Enhanced Role of Eosinophils in Radiomics-Based Diagnosis of Microvascular Invasion and Its Association with the Immune Microenvironment in Hepatocellular Carcinoma
Dong Liu,Jianmin Wu,Han Wang,Hui Dong,Lei Chen,Ningyang Jia
DOI: https://doi.org/10.2147/jhc.s484027
2024-09-26
Journal of Hepatocellular Carcinoma
Abstract:Dong Liu, 1, &ast Jianmin Wu, 2, &ast Han Wang, 3 Hui Dong, 3 Lei Chen, 4 Ningyang Jia 1 1 Department of Radiology, The Third Affiliated Hospital of Naval Medical University, Shanghai, 200433, People's Republic of China; 2 Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Fudan University, Shanghai, 200438, People's Republic of China; 3 Department of Pathology, The Third Affiliated Hospital of Naval Medical University, Shanghai, 200433, People's Republic of China; 4 The International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, 201805, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ningyang Jia; Lei Chen, Email ; Objective: To investigate the role of eosinophil counts (EC) in microvascular invasion (MVI) for enhancing the radiomics based diagnostic model. Additionally, its correlation with early recurrence and tumor immune microenvironment was explored. Methods: Propensity score matching was employed to evaluate on 462 cases whether EC was an independent risk factor for MVI. Subgroup analyses examined EC's effect on MVI across varying hypersplenism degrees. Univariate-multivariate logistic regression identified MVI's independent factors to develop a diagnostic model. Univariate-multivariate COX regression determined early recurrence factors. Co-detection by indexing (CODEX) constructed the immune score (IS), and Spearman correlation analyzed its association with peripheral immunity. Results: EC was an independent risk factor for MVI ( p =0.038, OR=1.304 (95% CI: 1.014– 1.677)), and its effect on MVI disappeared with the severity of hypersplenism. The diagnostic model with EC was significantly improved (AUC=0.787 (95% CI: 0.737– 0.836) vs AUC=0.748(95% CI: 0.694– 0.802, p =0.005)). MVI was an independent risk factor for early recurrence ( p < 0.001, HR = 2.254 (95% CI: 1.557– 3.263)). IS was negatively correlated with lymphocyte counts (R=− 0.311, p =0.022), and positively correlated with EC (R=0.301, p =0.027) and RS (R = 0.315, p = 0.018). Conclusion: EC was an independent risk factor for MVI and was related to the tumor immune microenvironment. EC should be included in the diagnosis of MVI to improve diagnostic efficiency. Keywords: hepatocellular carcinoma, eosinophils, radiomics Liver cancer ranks fifth among men and seventh among women among the top ten major cancer types in the United States based on the number of deaths in 2024. 1 Hepatocellular carcinoma (HCC) commonly exhibits postoperative recurrence, with a five-year recurrence rate reaching up to 70%. 2 Microvascular invasion (MVI), a critical pathological feature of HCC, has been established as a factor associated with recurrence and prognosis in prior studies. 3,4 While numerous studies have focused on the prediction and diagnosis of MVI through radiomics, they typically rely on clinical laboratory tests and imaging characteristics, often neglecting the role of peripheral immune cells. 5,6 Eosinophils have been found to promote tumor angiogenesis and normalization, and regulate the immune composition of the tumor immune microenvironment (TIME). 7 The trafficking of immune cells in the TIME and peripheral blood allows the peripheral eosinophils to reflect the eosinophils within the tumor, as the eosinophils within the TIME is scarce. 8 In this study, we utilized the propensity score matching (PSM) method to investigate whether eosinophil counts (EC) serve as an independent risk factor for MVI. We analyzed the changes in the role of EC in patients with varying degrees of hypersplenism within subgroups. Additionally, we examined whether a diagnostic model incorporating EC outperforms the traditional clinical-radiomics model. We assessed the correlations among EC, hypersplenism, MVI, and early recurrence, employing Co-detection by indexing (CODEX) technology to evaluate the TIME and explore the relationship between peripheral immunity and the TIME. The single-center, retrospective study was approved by the Ethical Committee of Eastern Hepatobiliary Surgery Hospital (EHBHKY2018-1–001), and each CODEX participant provided written informed consent, as was our previous study, 9 and it was conducted in adherence to the Declaration of Helsinki. Patient confidentiality was maintained by removing all identifying details from the data. Consecutive patients who underwent surgical resection for HCC at our hospital from January 2016 to -Abstract Truncated-
oncology